Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 21.19B 3.17B 2.82B 2.61B 2.37B 4.48B 301B 4.55B 31.37B 12.3B 157B 11.89B 11.63B 500B P/E 2026 *
14.3x
P/E 2027 * 12.4x
Enterprise Value 17.85B 2.67B 2.37B 2.2B 2B 3.77B 253B 3.83B 26.42B 10.36B 132B 10.01B 9.8B 421B EV / Sales 2026 *
0.6x
EV / Sales 2027 * 0.54x
Free-Float
34.77%
Yield 2026 *
5.06%
Yield 2027 * 5.6%
1 day-0.69%
1 week+1.36%
Current month+2.25%
1 month+1.25%
3 months-3.32%
6 months+6.65%
Current year+5.62%
1 week 18.5
Extreme 18.5
19.48
1 month 17.32
Extreme 17.32
19.48
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%+1.36%+8.70%-23.32% 3.19B
+2.17%+9.05%-41.13%+0.29% 15.34B
+12.04%-4.19%+7.38%-24.67% 7.14B
+0.43%+3.43%-12.09%-1.03% 6.3B
+1.47%+3.52%-12.42%+6.21% 6.24B
+1.52%+6.94%-51.38%-39.05% 6.1B
-3.17%+6.59%+3.89%-10.24% 4.69B
+2.67%+15.56%-32.63%-4.76% 3.44B
+0.26%+1.56%-14.59%-6.54% 3.23B
+0.75%-4.02%-28.01%-38.30% 3.02B
Average +1.75%+2.40%-17.23%-14.14% 5.87B
Weighted average by Cap. +2.31%+3.23%-21.18%-11.13%

Financials

2026 *2027 *
Net sales 29.54B 4.41B 3.92B 3.64B 3.31B 6.24B 419B 6.34B 43.72B 17.14B 219B 16.57B 16.22B 697B 32.52B 4.86B 4.32B 4B 3.64B 6.87B 461B 6.99B 48.13B 18.87B 241B 18.24B 17.85B 767B
Net income 1.49B 222M 197M 183M 166M 314M 21.08B 319M 2.2B 862M 11B 833M 816M 35.06B 1.71B 256M 227M 211M 192M 362M 24.27B 368M 2.53B 993M 12.67B 960M 939M 40.38B
Net Debt -3.34B -499M -444M -411M -374M -706M -47.38B -717M -4.94B -1.94B -24.72B -1.87B -1.83B -78.81B -3.76B -562M -500M -463M -421M -795M -53.34B -808M -5.57B -2.18B -27.83B -2.11B -2.06B -88.73B
Projected Income Statement - Annual - DaShenLin Pharmaceutical Group Co., Ltd.
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
16/10/26 CN¥18.61 -0.69% 11,084,185
15/10/26 CN¥18.74 -1.32% 13,992,116
14/10/26 CN¥18.99 +0.26% 14,142,196
13/10/26 CN¥18.94 -1.35% 14,478,966
12/10/26 CN¥19.20 +2.35% 16,594,205
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.61CNY
Average target price
23.75CNY
Spread / Average Target
+27.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock